KLP Kapitalforvaltning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
KLP Kapitalforvaltning's BMY Position: Q1 2026 in Review
KLP Kapitalforvaltning increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, buying an estimated $1.66M and bringing the position to 1,591,658 shares worth $96.5M. The position accounts for 0.38% of the portfolio, ranked #42.
KLP Kapitalforvaltning first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- KLP Kapitalforvaltning held 1,591,658 shares of Bristol-Myers Squibb worth $96.5M as of Q1 2026.
- KLP Kapitalforvaltning bought 28,500 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.66M.
- Bristol-Myers Squibb made up 0.38% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #42 holding.
- KLP Kapitalforvaltning first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.